VEGFA and neoplasm: Preclinical studies demonstrated that androgen deprivation downregulates vascular endothelial growth factor, leading to apoptosis of endothelial cells and decreased vascularization, and also reduces the dose of EBRT required to control 50% of the tumor, providing a biological basis for combination treatment [43].